INTZ Intrusion | $2.56
-0.4% | 7/7/2025 | Target Raised by | HC Wainwright | Analyst Scott Buck | Neutral -> Neutral | $1.50 -> $2.50 | Low | View details for HC Wainwright rating of Intrusion (NASDAQ:INTZ) on 7/7/2025 |
NAK Northern Dynasty Minerals | $1.79
+27.9% | 7/7/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.30 -> $2.50 | N/A | View details for HC Wainwright rating of Northern Dynasty Minerals (NYSEAMERICAN:NAK) on 7/7/2025 |
JSPR Jasper Therapeutics | $3.04
-55.1% | 7/7/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $40.00 -> $20.00 | Medium | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 7/7/2025 |
REPL Replimune Group | $9.65
+2.7% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $22.00 | Medium | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 7/3/2025 |
ZYME Zymeworks | $13.08
+0.3% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $13.00 | Medium | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 7/3/2025 |
BLTE Belite Bio | $58.63
-1.4% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 7/3/2025 |
NB NioCorp Developments | $2.39
-0.8% | 7/3/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.25 -> $4.00 | Low | View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 7/3/2025 |
MOGO Mogo | $1.99
-9.5% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 7/3/2025 |
IRON Disc Medicine | $53.38
-2.5% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $118.00 | Medium | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 7/3/2025 |
GANX Gain Therapeutics | $1.60
-5.3% | 7/3/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 7/3/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
TLX Telix Pharmaceuticals | $15.48
-3.7% | 7/3/2025 | Initiated by | HC Wainwright | Analyst Robert Burns | Buy | $23.00 | Low | View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 7/3/2025 |
ELVN Enliven Therapeutics | $19.59
-5.5% | 7/2/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $48.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 7/2/2025 |
ZVRA Zevra Therapeutics | $11.27
+15.7% | 7/2/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $26.00 | High | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 7/2/2025 |
BBAI BigBear.ai | $7.78
+0.4% | 7/1/2025 | Target Raised by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $6.00 -> $9.00 | High | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 7/1/2025 |
ARGX argenex | $546.04
+0.5% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $720.00 | Medium | View details for HC Wainwright rating of argenex (NASDAQ:ARGX) on 7/1/2025 |
NXTC NextCure | $0.44
+1.2% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 7/1/2025 |
PDSB PDS Biotechnology | $1.22
-8.3% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $13.00 | High | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 7/1/2025 |
TVTX Travere Therapeutics | $14.60
-2.7% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy | $30.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 7/1/2025 |
SMMT Summit Therapeutics | $22.61
-7.9% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $44.00 | Low | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/1/2025 |
TYRA Tyra Biosciences | $9.61
-3.9% | 7/1/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $30.00 | High | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 7/1/2025 |
LEXX Lexaria Bioscience | $0.87
-2.8% | 7/1/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $5.00 | Low | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 7/1/2025 |
VOR Vor Biopharma | $2.67
+39.8% | 6/30/2025 | Upgraded by | HC Wainwright | Analyst S. Ramakanth | Hold -> Strong-Buy | | High | View details for HC Wainwright rating of Vor Biopharma (NASDAQ:VOR) on 6/30/2025 |
OMER Omeros | $3.08
-3.8% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst B. Folkes | Buy -> Buy | $9.00 | High | View details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 6/27/2025 |
ZYXI Zynex | $2.51
+4.6% | 6/30/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 6/30/2025 |
LGO Largo | $1.37
-0.7% | 6/30/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.70 | High | View details for HC Wainwright rating of Largo (NYSE:LGO) on 6/30/2025 |
INUV Inuvo | $4.92
-0.6% | 6/30/2025 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $2.00 -> $15.00 | Medium | View details for HC Wainwright rating of Inuvo (NYSE:INUV) on 6/30/2025 |
CRMD CorMedix | $11.42
-1.7% | 6/30/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $20.00 | Medium | View details for HC Wainwright rating of CorMedix (NASDAQ:CRMD) on 6/30/2025 |
AARD Aardvark Therapeutics | $13.92
| 6/30/2025 | Initiated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy | $40.00 | High | View details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 6/30/2025 |
EXEL Exelixis | $44.16
-4.3% | 6/30/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $47.00 -> $53.00 | Low | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 6/30/2025 |
EWTX Edgewise Therapeutics | $12.61
-3.2% | 6/30/2025 | Initiated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $42.00 | High | View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/30/2025 |
CADL Candel Therapeutics | $4.99
-2.2% | 6/30/2025 | Upgraded by | HC Wainwright | Analyst Andrew Fein | Buy | $23.00 | Low | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 6/30/2025 |
VOR Vor Biopharma | $2.67
+39.8% | 6/30/2025 | Upgraded by | HC Wainwright | Analyst S. Ramakanth | Neutral -> Buy | $3.00 | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 6/30/2025 |
EDSA Edesa Biotech | $2.06
-1.0% | 6/27/2025 | Upgraded by | HC Wainwright | Analyst Yi Chen | Strong-Buy | $5.00 | Low | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 6/27/2025 |
LPCN Lipocine | $3.11
+0.3% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $8.00 | Medium | View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 6/27/2025 |
HIVE HIVE Digital Technologies | $2.27
-1.7% | 6/27/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $9.00 -> $6.00 | Low | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 6/27/2025 |
ALT Altimmune | $4.43
-6.9% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 | High | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 6/27/2025 |
IRD Opus Genetics | $0.99
-0.8% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 6/27/2025 |
OESX Orion Energy Systems | $0.61
+0.0% | 6/27/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $2.00 | High | View details for HC Wainwright rating of Orion Energy Systems (NASDAQ:OESX) on 6/27/2025 |
CRNX Crinetics Pharmaceuticals | $29.06
-2.5% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $81.00 | High | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 6/27/2025 |
PSTV Plus Therapeutics | $0.30
+1.4% | 6/27/2025 | Target Lowered by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $5.50 -> $3.00 | Low | View details for HC Wainwright rating of Plus Therapeutics (NASDAQ:PSTV) on 6/27/2025 |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
CRSP CRISPR Therapeutics | $51.19
-1.9% | 6/27/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $65.00 | High | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 6/27/2025 |
EPRX Eupraxia Pharmaceuticals | $5.54
+2.8% | 6/26/2025 | Initiated by | HC Wainwright | Analyst B. Folkes | Buy | $12.00 | High | View details for HC Wainwright rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 6/26/2025 |
IVVD Invivyd | $0.70
-4.3% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 6/26/2025 |
ANRO Alto Neuroscience | $2.30
-2.1% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 6/26/2025 |
CMPS COMPASS Pathways | $3.31
+1.5% | 6/23/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 6/23/2025 |
CDTX Cidara Therapeutics | $48.30
-1.0% | 6/23/2025 | Reiterated by | HC Wainwright | Analyst S. Nik | Buy -> Buy | $41.00 -> $53.00 | Low | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 6/23/2025 |
BTBT Bit Digital | $3.48
+18.4% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 6/26/2025 |
IONS Ionis Pharmaceuticals | $41.78
-2.8% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 6/26/2025 |
CGTX Cognition Therapeutics | $0.58
+42.9% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/26/2025 |
ACAD ACADIA Pharmaceuticals | $20.88
-0.3% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 6/26/2025 |
BIIB Biogen | $130.13
-2.1% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $187.00 | Low | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 6/26/2025 |
KYMR Kymera Therapeutics | $43.81
-2.2% | 6/26/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $54.00 -> $60.00 | Low | View details for HC Wainwright rating of Kymera Therapeutics (NASDAQ:KYMR) on 6/26/2025 |
EPRX Eupraxia Pharmaceuticals | $5.54
+2.8% | 6/26/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $12.00 | Low | View details for HC Wainwright rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 6/26/2025 |
FEMY Femasys | $0.93
-0.2% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 6/25/2025 |
VKTX Viking Therapeutics | $27.51
-2.4% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 | High | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 6/25/2025 |
PHIO Phio Pharmaceuticals | $2.55
+6.3% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst M. Keller | Buy -> Buy | $14.00 | High | View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 6/25/2025 |
TRNS Transcat | $86.35
-3.9% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $116.00 | Medium | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 6/25/2025 |
USAU US Gold | $12.82
+1.1% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of US Gold (NASDAQ:USAU) on 6/25/2025 |
SRPT Sarepta Therapeutics | $17.32
-5.0% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Sell | | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/25/2025 |
CRWV CoreWeave | $159.70
-3.3% | 6/25/2025 | Initiated by | HC Wainwright | Analyst Kevin Dede | Neutral | | High | View details for HC Wainwright rating of CoreWeave (NASDAQ:CRWV) on 6/25/2025 |
ACRS Aclaris Therapeutics | $1.46
+1.4% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $16.00 | High | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 6/25/2025 |
BNTX BioNTech | $110.05
+0.0% | 6/25/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $138.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 6/25/2025 |
SGMO Sangamo Therapeutics | $0.51
-2.9% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 | High | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 6/24/2025 |
NKTR Nektar Therapeutics | $23.47
-5.2% | 6/24/2025 | Target Raised by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $120.00 | High | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 6/24/2025 |
KRYS Krystal Biotech | $139.74
-2.3% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $240.00 | Low | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 6/24/2025 |
CAPR Capricor Therapeutics | $9.90
-3.4% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 6/24/2025 |
NUVL Nuvalent | $77.93
-3.2% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $110.00 -> $130.00 | High | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 6/24/2025 |
OCGN Ocugen | $0.97
+1.4% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 | High | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 6/24/2025 |
RDW Redwire | $15.50
-3.1% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $26.00 | Medium | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 6/24/2025 |
ATNM Actinium Pharmaceuticals | $1.42
-1.4% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 6/24/2025 |
LYEL Lyell Immunopharma | $9.15
-5.6% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $10.00 | High | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 6/24/2025 |
LXRX Lexicon Pharmaceuticals | $0.87
-3.1% | 6/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 | High | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 6/24/2025 |
LCTX Lineage Cell Therapeutics | $0.95
-5.9% | 6/23/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 6/23/2025 |
SEPN Septerna | $10.85
-4.6% | 6/23/2025 | Initiated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy | $26.00 | Low | View details for HC Wainwright rating of Septerna (NASDAQ:SEPN) on 6/23/2025 |
VRTX Vertex Pharmaceuticals | $459.41
0.0% | 6/23/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $550.00 | Low | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 6/23/2025 |
DPRO Draganfly | $3.43
+9.9% | 6/20/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $5.00 -> $3.50 | High | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 6/20/2025 |
WRN Western Copper & Gold | $1.23
-1.2% | 6/18/2025 | Target Set by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.25 -> $4.00 | Low | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 6/18/2025 |
ROIV Roivant Sciences | $10.74
-2.3% | 6/18/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 | High | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 6/18/2025 |
ELDN Eledon Pharmaceuticals | $3.11
+1.0% | 6/18/2025 | Upgraded by | HC Wainwright | Analyst Yi Chen | Buy | $9.00 | High | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 6/18/2025 |
ARDX Ardelyx | $4.35
+1.9% | 6/18/2025 | Initiated by | HC Wainwright | Analyst Matthew Caufield | Buy | $10.00 | Low | View details for HC Wainwright rating of Ardelyx (NASDAQ:ARDX) on 6/18/2025 |
VERV Verve Therapeutics | $11.16
-1.1% | 6/18/2025 | Downgraded by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Neutral | $13.50 | Low | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 6/18/2025 |
CDTX Cidara Therapeutics | $48.30
-1.0% | 6/18/2025 | Upgraded by | HC Wainwright | Analyst Joseph Pantginis | Buy | $41.00 | Medium | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 6/18/2025 |
MLYS Mineralys Therapeutics | $13.53
-6.9% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $42.00 | Low | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 6/17/2025 |
SAGE Sage Therapeutics | $9.17
-0.3% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Neutral -> Neutral | $12.00 | Low | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 6/17/2025 |
ELBM Electra Battery Materials | $1.13
+4.2% | 6/17/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.40 -> $2.20 | Low | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 6/17/2025 |
PPTA Perpetua Resources | $13.11
+5.3% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $27.50 | Medium | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 6/17/2025 |
IRON Disc Medicine | $53.38
-2.5% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $118.00 | High | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 6/17/2025 |
AQST Aquestive Therapeutics | $3.70
-0.5% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 6/17/2025 |
SLDB Solid Biosciences | $4.91
-2.4% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $20.00 | High | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 6/17/2025 |
BLRX BioLineRx | $4.32
-3.8% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | | High | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 6/17/2025 |
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad) Obscure Metal More Valuable than Gold and Bitcoin… COMBINED?
This strange "AI Metal" holds the key to the $100 trillion AI boom.
Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world.
And you won't believe what he uncovered. Click here to see the details because this could be the biggest tech story of this decade. |
GALT Galectin Therapeutics | $2.15
-1.4% | 6/17/2025 | Initiated by | HC Wainwright | Analyst E. Arce | Buy | $6.00 | High | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 6/17/2025 |
ESPR Esperion Therapeutics | $1.11
-5.1% | 6/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 6/17/2025 |
GROY Gold Royalty | $2.38
+3.5% | 6/13/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $5.75 | High | View details for HC Wainwright rating of Gold Royalty (NYSE:GROY) on 6/13/2025 |
ACLX Arcellx | $65.55
-2.4% | 6/16/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $115.00 | High | View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 6/16/2025 |
BNTX BioNTech | $110.05
+0.0% | 6/16/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $145.00 -> $138.00 | Medium | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 6/16/2025 |
NTLA Intellia Therapeutics | $10.25
-4.6% | 6/16/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 | High | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/16/2025 |
SRPT Sarepta Therapeutics | $17.32
-5.0% | 6/16/2025 | Downgraded by | HC Wainwright | Analyst M. Kapoor | Neutral -> Sell | | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/16/2025 |
URGN Urogen Pharma | $13.49
-0.7% | 6/16/2025 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Buy | $50.00 | High | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 6/16/2025 |
ATXS Astria Therapeutics | $6.20
+6.7% | 6/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 | Medium | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 6/13/2025 |
CAPR Capricor Therapeutics | $9.90
-3.4% | 6/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 6/13/2025 |
RZLV Rezolve AI | $2.65
-6.0% | 6/13/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $4.00 | Medium | View details for HC Wainwright rating of Rezolve AI (NASDAQ:RZLV) on 6/13/2025 |
CLDX Celldex Therapeutics | $20.98
-4.6% | 6/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $50.00 | High | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/13/2025 |
DGXX Digi Power X | $2.93
-4.6% | 6/12/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $2.50 | High | View details for HC Wainwright rating of Digi Power X (NASDAQ:DGXX) on 6/12/2025 |
WWR Westwater Resources | $0.60
+0.5% | 6/12/2025 | Target Lowered by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.50 -> $2.00 | Low | View details for HC Wainwright rating of Westwater Resources (NASDAQ:WWR) on 6/12/2025 |
EXEL Exelixis | $44.16
-4.3% | 6/12/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $47.00 | Medium | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 6/12/2025 |
CNTB Connect Biopharma | $1.14
-2.5% | 6/12/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy -> Buy | $7.00 | Medium | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 6/12/2025 |
FEMY Femasys | $0.93
-0.2% | 6/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 6/11/2025 |
CABA Cabaletta Bio | $1.49
-8.6% | 6/11/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 | Medium | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 6/11/2025 |
PDSB PDS Biotechnology | $1.22
-8.3% | 6/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 6/11/2025 |
ARTV Artiva Biotherapeutics | $1.58
-1.9% | 6/11/2025 | Upgraded by | HC Wainwright | Analyst E. White | Buy | $12.00 | High | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 6/11/2025 |
TVTX Travere Therapeutics | $14.60
-2.7% | 6/11/2025 | Upgraded by | HC Wainwright | Analyst Ed Arce | Buy | $30.00 | High | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 6/11/2025 |
INSM Insmed | $96.95
-0.9% | 6/11/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $90.00 -> $120.00 | High | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 6/11/2025 |
ARGX argenex | $546.04
+0.5% | 6/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $720.00 | Medium | View details for HC Wainwright rating of argenex (NASDAQ:ARGX) on 6/10/2025 |
LPCN Lipocine | $3.11
+0.3% | 6/10/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $8.00 | High | View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 6/10/2025 |
AXSM Axsome Therapeutics | $107.50
+2.0% | 6/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 6/10/2025 |
OMER Omeros | $3.08
-3.8% | 6/10/2025 | Initiated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy | $9.00 | High | View details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 6/10/2025 |
ELEV Elevation Oncology | $0.38
-2.3% | 6/10/2025 | Downgraded by | HC Wainwright | Analyst Swayampakula Ramakanth | Strong-Buy -> Neutral | | Low | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 6/10/2025 |
EVEX EVE | $7.53
+2.4% | 6/9/2025 | Target Raised by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $6.00 -> $8.00 | Low | View details for HC Wainwright rating of EVE (NYSE:EVEX) on 6/9/2025 |
ACHR Archer Aviation | $10.01
-1.6% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.00 -> $18.00 | High | View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 6/9/2025 |
JOBY Joby Aviation | $10.64
+0.9% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $9.00 -> $13.00 | Medium | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 6/9/2025 |
EVTL Vertical Aerospace | $6.87
-2.7% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.00 -> $15.00 | High | View details for HC Wainwright rating of Vertical Aerospace (NYSE:EVTL) on 6/9/2025 |
PYPD PolyPid | $3.45
-1.4% | 6/9/2025 | Target Raised by | HC Wainwright | Analyst B. Folkes | Buy -> Buy | $11.00 -> $13.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 6/9/2025 |
COYA Coya Therapeutics | $5.87
-1.5% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $18.00 | Medium | View details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 6/9/2025 |
BWAY Brainsway | $13.37
+1.0% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $16.00 | High | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 6/9/2025 |
PHAT Phathom Pharmaceuticals | $8.66
-2.9% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $20.00 | Medium | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 6/9/2025 |
HRTX Heron Therapeutics | $2.15
-2.3% | 6/9/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $6.00 | High | View details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 6/9/2025 |
BBIO BridgeBio Pharma | $43.50
-1.1% | 6/9/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $53.00 -> $56.00 | Medium | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 6/9/2025 |
ANVS Annovis Bio | $2.39
+1.3% | 6/9/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $30.00 -> $12.00 | Medium | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 6/9/2025 |
ARVN Arvinas | $7.79
-2.0% | 6/2/2025 | Target Set by | HC Wainwright | Analyst Andrew Fein | | $24.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 6/2/2025 |
FUFU BitFuFu | $3.48
+1.2% | 6/6/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 6/6/2025 |
BNTX BioNTech | $110.05
+0.0% | 6/5/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $134.00 -> $145.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 6/5/2025 |
PHIO Phio Pharmaceuticals | $2.55
+6.3% | 6/5/2025 | Initiated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $14.00 | High | View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 6/5/2025 |
MIST Milestone Pharmaceuticals | $2.17
+11.9% | 6/5/2025 | Upgraded by | HC Wainwright | Analyst Brandon Folkes | Buy | $5.00 | High | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 6/5/2025 |
TIL Instil Bio | $23.64
-14.0% | 6/5/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $125.00 -> $125.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 6/5/2025 |
ATYR aTyr Pharma | $5.30
-0.2% | 6/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 | High | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:ATYR) on 6/4/2025 |
IBRX ImmunityBio | $2.72
| 6/4/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 | High | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 6/4/2025 |
IMMX Immix Biopharma | $2.62
+2.7% | 6/4/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $7.00 | Medium | View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 6/4/2025 |
AKBA Akebia Therapeutics | $3.63
+0.3% | 6/4/2025 | Initiated by | HC Wainwright | Analyst Matthew Caufield | Buy | $8.00 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 6/4/2025 |
ANAB AnaptysBio | $23.45
-1.3% | 6/4/2025 | Upgraded by | HC Wainwright | Analyst E. Bodnar | Neutral -> Buy | $22.00 -> $38.00 | High | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 6/4/2025 |
AGEN Agenus | $5.18
-14.7% | 6/4/2025 | Upgraded by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Buy | $25.00 | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 6/4/2025 |
White House to reset Social Security? (Ad) Elon Musk's parting DOGE gift looks set to shock America...
A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.  And it could have a major impact on how you collect Social Security - Click here to understand what' |
ACTU Actuate Therapeutics | $6.01
-8.8% | 6/3/2025 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy | $20.00 | Low | View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 6/3/2025 |
PTGX Protagonist Therapeutics | $49.87
-2.3% | 6/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 6/3/2025 |
YTRA Yatra Online | $0.97
-0.6% | 6/3/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 6/3/2025 |
APLD Applied Digital | $9.66
-7.6% | 6/3/2025 | Target Raised by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $12.00 | Low | View details for HC Wainwright rating of Applied Digital (NASDAQ:APLD) on 6/3/2025 |
ANL Adlai Nortye | $1.42
-5.3% | 6/2/2025 | Downgraded by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | | High | View details for HC Wainwright rating of Adlai Nortye (NASDAQ:ANL) on 6/2/2025 |
IMCR Immunocore | $32.41
-1.8% | 6/2/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 6/2/2025 |
SNSE Sensei Biotherapeutics | $9.15
+1.3% | 6/2/2025 | Upgraded by | HC Wainwright | Analyst Matthew Kelsey | Buy | $100.00 | High | View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:SNSE) on 6/2/2025 |
VERA Vera Therapeutics | $22.97
-4.3% | 6/2/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $75.00 -> $85.00 | High | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 6/2/2025 |
PYPD PolyPid | $3.45
-1.4% | 6/2/2025 | Upgraded by | HC Wainwright | Analyst Brandon Folkes | Buy | $11.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 6/2/2025 |
CRDL Cardiol Therapeutics | $1.45
-5.8% | 6/2/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $9.00 | High | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 6/2/2025 |
SENS Senseonics | $0.49
-2.6% | 6/2/2025 | Target Set by | HC Wainwright | Analyst Sean Lee | Buy | $1.10 | Low | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 6/2/2025 |
AVTX Avalo Therapeutics | $4.75
-4.2% | 6/2/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Hold -> Buy | $15.00 | High | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 6/2/2025 |
VRNA Verona Pharma PLC American Depositary Share | $91.20
-0.4% | 6/2/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $85.00 -> $90.00 | High | View details for HC Wainwright rating of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) on 6/2/2025 |
GEVO Gevo | $1.44
-4.0% | 5/30/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 5/30/2025 |
ICCM IceCure Medical | $1.05
-0.5% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 5/29/2025 |
EYPT Eyepoint Pharmaceuticals | $9.49
-2.4% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $22.00 | Medium | View details for HC Wainwright rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 5/29/2025 |
OCUL Ocular Therapeutix | $9.61
-0.1% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 | Medium | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 5/29/2025 |
LPCN Lipocine | $3.11
+0.3% | 5/29/2025 | Upgraded by | HC Wainwright | Analyst Yi Chen | Strong-Buy | $8.00 | Low | View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 5/29/2025 |
QURE uniQure | $14.31
-0.8% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $70.00 | Medium | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 5/29/2025 |
PEPG PepGen | $1.11
-9.0% | 5/29/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $14.00 -> $8.00 | High | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 5/29/2025 |
SVRA Savara | $2.34
+6.8% | 5/29/2025 | Downgraded by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $6.00 -> $2.00 | High | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 5/29/2025 |
HALO Halozyme Therapeutics | $54.22
+0.4% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $72.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/29/2025 |
NTLA Intellia Therapeutics | $10.25
-4.6% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 | High | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/29/2025 |
DMAC DiaMedica Therapeutics | $3.63
-3.5% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 5/29/2025 |
ETON Eton Pharmaceuticals | $14.39
-0.4% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $35.00 | High | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 5/29/2025 |
IVVD Invivyd | $0.70
-4.3% | 5/28/2025 | Target Lowered by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $5.00 | Medium | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 5/28/2025 |
YTRA Yatra Online | $0.97
-0.6% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $3.00 | High | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 5/28/2025 |
NPCE NeuroPace | $10.22
-1.6% | 5/28/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy | $18.00 | Medium | View details for HC Wainwright rating of NeuroPace (NASDAQ:NPCE) on 5/28/2025 |
AURA Aura Biosciences | $6.16
-6.1% | 5/28/2025 | Upgraded by | HC Wainwright | Analyst Andres Maldonado | Buy | $22.00 | Low | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 5/28/2025 |
XOMA XOMA Royalty | $26.17
-2.9% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 | Low | View details for HC Wainwright rating of XOMA Royalty (NASDAQ:XOMA) on 5/28/2025 |
TRVI Trevi Therapeutics | $5.95
| 5/28/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy -> Buy | $21.00 | Medium | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 5/28/2025 |
BLRX BioLineRx | $4.32
-3.8% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | | Medium | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 5/28/2025 |
ROIV Roivant Sciences | $10.74
-2.3% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 | High | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 5/28/2025 |
FNV Franco-Nevada | $165.30
+0.1% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $180.00 -> $195.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/28/2025 |
LQDA Liquidia Technologies | $12.45
+2.1% | 5/28/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $35.00 | High | View details for HC Wainwright rating of Liquidia Technologies (NASDAQ:LQDA) on 5/28/2025 |
VIGL Vigil Neuroscience | $7.99
| 5/27/2025 | Downgraded by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $14.00 -> $8.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/27/2025 |
UNCY Unicycive Therapeutics | $4.69
+2.0% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Swayampakula Ramakanth | Strong-Buy | $90.00 | High | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/27/2025 |
TARS Tarsus Pharmaceuticals | $39.93
-3.0% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Matthew Caufield | Buy | $72.00 | High | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/27/2025 |
CGTX Cognition Therapeutics | $0.58
+42.9% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 5/27/2025 |
KYTX Kyverna Therapeutics | $2.55
-9.3% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Buy | $4.00 -> $5.00 | High | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 5/27/2025 |
OVID Ovid Therapeutics | $0.37
+10.5% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $2.00 -> $1.50 | Medium | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 5/27/2025 |
PRTA Prothena | $6.29
-2.2% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $30.00 -> $14.00 | High | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/27/2025 |
CLSD Clearside Biomedical | $0.82
+0.3% | 5/23/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $6.00 -> $5.00 | Medium | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 5/23/2025 |
USAU US Gold | $12.82
+1.1% | 5/23/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $14.00 -> $15.00 | Medium | View details for HC Wainwright rating of US Gold (NASDAQ:USAU) on 5/23/2025 |
DCTH Delcath Systems | $12.24
-3.5% | 5/23/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $24.00 -> $29.00 | Medium | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 5/23/2025 |
KALA KALA BIO | $5.28
+3.5% | 5/23/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $12.00 | Low | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 5/23/2025 |
BNTX BioNTech | $110.05
+0.0% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $134.00 -> $134.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/22/2025 |
AXSM Axsome Therapeutics | $107.50
+2.0% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 -> $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/22/2025 |
URGN Urogen Pharma | $13.49
-0.7% | 5/22/2025 | Downgraded by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Neutral | | Medium | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 5/22/2025 |
MDWD MediWound | $19.27
-0.4% | 5/22/2025 | Target Set by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $31.00 | Medium | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 5/22/2025 |
White House to reset Social Security? (Ad) Elon Musk's parting DOGE gift looks set to shock America...
A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' |
SRPT Sarepta Therapeutics | $17.32
-5.0% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2025 |
TIL Instil Bio | $23.64
-14.0% | 5/22/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 5/22/2025 |
RAPT Rapt Therapeutics | $8.16
+1.4% | 5/22/2025 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Strong-Buy | $48.00 | High | View details for HC Wainwright rating of Rapt Therapeutics (NASDAQ:RAPT) on 5/22/2025 |
GLXY Galaxy Digital | $19.69
-9.5% | 5/16/2025 | Upgraded by | HC Wainwright | Analyst M. Colonnese | Strong-Buy | | High | View details for HC Wainwright rating of Galaxy Digital (NASDAQ:GLXY) on 5/16/2025 |
IDN Intellicheck | $5.45
+1.5% | 5/21/2025 | Target Set by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $6.00 | High | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 5/21/2025 |
TRNS Transcat | $86.35
-3.9% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $106.00 -> $116.00 | High | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 5/21/2025 |
DTIL Precision BioSciences | $4.31
-0.7% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 5/21/2025 |
ANY Sphere 3D | $0.59
-4.8% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 5/21/2025 |
ONCY Oncolytics Biotech | $1.01
+9.8% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 5/21/2025 |
COGT Cogent Biosciences | $9.35
+23.4% | 5/20/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $14.00 -> $12.00 | High | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 5/20/2025 |
TMC TMC the metals | $6.65
-6.5% | 5/20/2025 | Initiated by | HC Wainwright | Analyst Heiko Ihle | Buy | $5.50 | High | View details for HC Wainwright rating of TMC the metals (NASDAQ:TMC) on 5/20/2025 |
QSI Quantum-Si | $1.83
-14.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.50 | High | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 5/19/2025 |
TRDA Entrada Therapeutics | $6.97
-3.6% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 5/20/2025 |
FENC Adherex Technologies | $8.47
-3.8% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Adherex Technologies (NASDAQ:FENC) on 5/20/2025 |
IONS Ionis Pharmaceuticals | $41.78
-2.8% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/20/2025 |
CRSP CRISPR Therapeutics | $51.19
-1.9% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $65.00 -> $65.00 | Low | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/20/2025 |
NTLA Intellia Therapeutics | $10.25
-4.6% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/20/2025 |
PRME Prime Medicine | $3.80
+22.2% | 5/20/2025 | Downgraded by | HC Wainwright | Analyst Arthur He | Buy -> Neutral | | High | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 5/20/2025 |
ARWR Arrowhead Pharmaceuticals | $16.84
+0.3% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | Medium | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/20/2025 |
ATAI atai Life Sciences | $2.75
-0.7% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of atai Life Sciences (NASDAQ:ATAI) on 5/20/2025 |
FHTX Foghorn Therapeutics | $4.78
-6.8% | 5/14/2025 | Upgraded by | HC Wainwright | Analyst A. Fein | Strong-Buy | | High | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/14/2025 |
ARMP Armata Pharmaceuticals | $2.04
-6.0% | 5/19/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 5/19/2025 |
BITF Bitfarms | $1.03
+1.0% | 5/14/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Medium | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 5/14/2025 |
PHGE BiomX | $0.45
-39.8% | 5/16/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 5/16/2025 |
IOBT IO Biotech | $1.43
-4.0% | 5/14/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 5/14/2025 |
LPTH LightPath Technologies | $2.95
-3.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 5/19/2025 |
BTBT Bit Digital | $3.48
+18.4% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 5/19/2025 |
PTGX Protagonist Therapeutics | $49.87
-2.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/19/2025 |
ALDX Aldeyra Therapeutics | $4.35
+1.2% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/19/2025 |
OPTN OptiNose | $9.60
| 5/19/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Neutral -> Neutral | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 5/19/2025 |
CASI CASI Pharmaceuticals | $1.33
+2.2% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of CASI Pharmaceuticals (NASDAQ:CASI) on 5/19/2025 |
RNXT RenovoRx | $1.32
-2.9% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 5/19/2025 |
PYXS Pyxis Oncology | $1.14
+3.6% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 5/19/2025 |
CELC Celcuity | $13.34
-3.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $27.00 -> $27.00 | Low | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 5/19/2025 |
MIRM Mirum Pharmaceuticals | $50.47
+0.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $73.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/19/2025 |
ATYR aTyr Pharma | $5.30
-0.2% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 -> $35.00 | Medium | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:ATYR) on 5/19/2025 |
BNTC Benitec Biopharma | $13.49
+2.4% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 5/19/2025 |
CRIS Curis | $1.74
-3.9% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $17.00 | Medium | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 5/19/2025 |
GANX Gain Therapeutics | $1.60
-5.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 5/19/2025 |
ACAD ACADIA Pharmaceuticals | $20.88
-0.3% | 5/19/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $27.00 -> $32.00 | Low | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/19/2025 |
ASRT Assertio | $0.66
+0.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $3.50 -> $3.50 | Low | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 5/19/2025 |
VANI Vivani Medical | $1.27
+0.8% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 5/19/2025 |
YMAB Y-mAbs Therapeutics | $4.22
-1.9% | 5/19/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $12.00 -> $11.00 | Medium | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/19/2025 |
WYY WidePoint | $3.26
-4.4% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of WidePoint (NYSEAMERICAN:WYY) on 5/16/2025 |
KSCP Knightscope | $6.81
+25.6% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Knightscope (NASDAQ:KSCP) on 5/16/2025 |
WKSP Worksport | $3.79
+9.9% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $11.50 -> $11.50 | Medium | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 5/16/2025 |
LGO Largo | $1.37
-0.7% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.90 -> $3.70 | High | View details for HC Wainwright rating of Largo (NYSE:LGO) on 5/16/2025 |
CVKD Cadrenal Therapeutics | $12.95
-0.2% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $32.00 -> $32.00 | Low | View details for HC Wainwright rating of Cadrenal Therapeutics (NASDAQ:CVKD) on 5/16/2025 |
PHGE BiomX | $0.44
| 5/16/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $15.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 5/16/2025 |
ZBIO Zenas BioPharma | $9.79
-2.4% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 5/16/2025 |
HURA TuHURA Biosciences | $2.40
-3.2% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of TuHURA Biosciences (NASDAQ:HURA) on 5/16/2025 |
BCAX Bicara Therapeutics | $9.01
-0.2% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $44.00 -> $41.00 | High | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/16/2025 |
ACOG Alpha Cognition | $11.24
+7.4% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Alpha Cognition (NASDAQ:ACOG) on 5/16/2025 |
LXEO Lexeo Therapeutics | $4.54
+2.0% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $15.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/16/2025 |
DEFT DeFi Technologies | $2.81
-10.5% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $4.50 -> $5.50 | Low | View details for HC Wainwright rating of DeFi Technologies (NASDAQ:DEFT) on 5/15/2025 |
AQST Aquestive Therapeutics | $3.70
-0.5% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/15/2025 |
IREN IREN | $16.95
+0.8% | 5/15/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $22.00 -> $21.00 | Low | View details for HC Wainwright rating of IREN (NASDAQ:IREN) on 5/15/2025 |
ASM Avino Silver & Gold Mines | $3.69
+5.4% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.20 -> $2.80 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/15/2025 |
ADVM Adverum Biotechnologies | $2.23
-2.2% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 5/15/2025 |
CTMX CytomX Therapeutics | $2.37
-5.2% | 5/15/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/15/2025 |
